Leukemia

The 5th DKMS Linked Against Leukemia Gala, held on April 28 at Cipriani Wall Street, broke all records of previous years and raised $2.5M to support the fight against leukemia and other blood related cancers.

Roche Holding AG's arthritis and cancer drug, Rituxan, received approval from the U.S. Food and Drug Administration (FDA) to treat two rare disorders that cause blood vessel inflammation.

A U.S. Environmental Protection Agency draft assessment of the potential health effects associated with formaldehyde exposure needs substantial revision, says a new report from the National Research Council, which recommends improvements for EPA's final assessment.

After the Internet backlash over the last few days, Food Network's Barefoot Contessa host, Ina Garten finally agreed to meet with a 6-year-old leukemia victim.

The disaster at the Fukushima Daiichi nuclear power stations in Japan could have long-lasting effects that go beyond the radiation exposure measured directly from the site, according to one anti-nuclear group.

China used its regulatory powers to scour the books of Citibank Shanghai in a hostile and extraordinarily intrusive 2007 audit that appeared primarily aimed at controlling Citi's growth and uncovering its secrets to success, the bank's top China executive at the time told U.S. officials.

Famous opera singer José Carreras and musician A. R. Rahman received the World Economic Forum Crystal Award 2011 on Wednesday at the opening ceremony.

The top pre-market NASDAQ stock market gainers are: BioSante Pharmaceuticals, Harris & Harris Group, LM Ericsson Telephone, Savient Pharmaceuticals, and Skyworks Solutions. The top pre-market NASDAQ stock market losers are: Tellabs, Eagle Bulk Shipping, Rediff.com India, Randgold Resources, and DryShips.

German researchers say they have cured a man of HIV infection that could prove to be a scientific advance but researchers familiar with the work feel it is not necessarily a treatment advance.

Swiss drug maker Novartis will pay $12.9 billion to buy the remaining shares of Alcon it doesn't already own to broaden its presence in the booming eye-care market, which is expected to outgrow the pharmaceuticals market in coming years.

The top pre-market NASDAQ stock market gainers are: Verigy, Radware, Rambus, Nova Measuring Instruments, ASM International, VIVUS, optionsXpress Holdings, Ariad Pharmaceuticals, Geron, and DryShips.

U.S. health regulators approved Roche's (ROG.VX) blockbuster cancer drug Rituxan to treat the most common form of leukemia in adults.